These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 24167377)
1. Fecal S100A12 in healthy infants and children. Day AS; Ehn M; Gearry RB; Lemberg DA; Leach ST Dis Markers; 2013; 35(5):295-9. PubMed ID: 24167377 [TBL] [Abstract][Full Text] [Related]
2. Fecal S100A12: a novel noninvasive marker in children with Crohn's disease. de Jong NS; Leach ST; Day AS Inflamm Bowel Dis; 2006 Jul; 12(7):566-72. PubMed ID: 16804393 [TBL] [Abstract][Full Text] [Related]
3. Fecal S100A12 and fecal calprotectin as noninvasive markers for inflammatory bowel disease in children. Sidler MA; Leach ST; Day AS Inflamm Bowel Dis; 2008 Mar; 14(3):359-66. PubMed ID: 18050298 [TBL] [Abstract][Full Text] [Related]
4. Reference values of fecal calgranulin C (S100A12) in school aged children and adolescents. Heida A; Kobold ACM; Wagenmakers L; van de Belt K; van Rheenen PF Clin Chem Lab Med; 2017 Nov; 56(1):126-131. PubMed ID: 28708568 [TBL] [Abstract][Full Text] [Related]
6. Improving relapse prediction in inflammatory bowel disease by neutrophil-derived S100A12. Däbritz J; Langhorst J; Lügering A; Heidemann J; Mohr M; Wittkowski H; Krummenerl T; Foell D Inflamm Bowel Dis; 2013 May; 19(6):1130-8. PubMed ID: 23377171 [TBL] [Abstract][Full Text] [Related]
7. Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome. Kaiser T; Langhorst J; Wittkowski H; Becker K; Friedrich AW; Rueffer A; Dobos GJ; Roth J; Foell D Gut; 2007 Dec; 56(12):1706-13. PubMed ID: 17675327 [TBL] [Abstract][Full Text] [Related]
8. Multiple Opportunistic Pathogens, but Not Pre-existing Inflammation, May Be Associated with Necrotizing Enterocolitis. Leach ST; Lui K; Naing Z; Dowd SE; Mitchell HM; Day AS Dig Dis Sci; 2015 Dec; 60(12):3728-34. PubMed ID: 26250832 [TBL] [Abstract][Full Text] [Related]
10. Subclinical intestinal inflammation in siblings of children with Crohn's disease. Pham M; Leach ST; Lemberg DA; Day AS Dig Dis Sci; 2010 Dec; 55(12):3502-7. PubMed ID: 20931283 [TBL] [Abstract][Full Text] [Related]
11. Accuracies of serum and fecal S100 proteins (calprotectin and calgranulin C) to predict the response to TNF antagonists in patients with Crohn's disease. Boschetti G; Garnero P; Moussata D; Cuerq C; Préaudat C; Duclaux-Loras R; Mialon A; Drai J; Flourié B; Nancey S Inflamm Bowel Dis; 2015 Feb; 21(2):331-6. PubMed ID: 25625487 [TBL] [Abstract][Full Text] [Related]
12. S100A12 and hBD2 correlate with the composition of the fecal microflora in ELBW infants and expansion of E. coli is associated with NEC. Jenke AC; Postberg J; Mariel B; Hensel K; Foell D; Däbritz J; Wirth S Biomed Res Int; 2013; 2013():150372. PubMed ID: 24307989 [TBL] [Abstract][Full Text] [Related]
13. S100A8 and S100A9 Are Important for Postnatal Development of Gut Microbiota and Immune System in Mice and Infants. Willers M; Ulas T; Völlger L; Vogl T; Heinemann AS; Pirr S; Pagel J; Fehlhaber B; Halle O; Schöning J; Schreek S; Löber U; Essex M; Hombach P; Graspeuntner S; Basic M; Bleich A; Cloppenborg-Schmidt K; Künzel S; Jonigk D; Rupp J; Hansen G; Förster R; Baines JF; Härtel C; Schultze JL; Forslund SK; Roth J; Viemann D Gastroenterology; 2020 Dec; 159(6):2130-2145.e5. PubMed ID: 32805279 [TBL] [Abstract][Full Text] [Related]
14. Association between fecal S100A12 concentration and histologic, endoscopic, and clinical disease severity in dogs with idiopathic inflammatory bowel disease. Heilmann RM; Grellet A; Allenspach K; Lecoindre P; Day MJ; Priestnall SL; Toresson L; Procoli F; Grützner N; Suchodolski JS; Steiner JM Vet Immunol Immunopathol; 2014 Apr; 158(3-4):156-66. PubMed ID: 24518653 [TBL] [Abstract][Full Text] [Related]
15. Serum and mucosal S100 proteins, calprotectin (S100A8/S100A9) and S100A12, are elevated at diagnosis in children with inflammatory bowel disease. Leach ST; Yang Z; Messina I; Song C; Geczy CL; Cunningham AM; Day AS Scand J Gastroenterol; 2007 Nov; 42(11):1321-31. PubMed ID: 17852869 [TBL] [Abstract][Full Text] [Related]
16. Analytical validation of an enzyme-linked immunosorbent assay for the quantification of S100A12 in the serum and feces of cats. Bridges CS; Grützner N; Suchodolski JS; Steiner JM; Heilmann RM Vet Clin Pathol; 2019 Dec; 48(4):754-761. PubMed ID: 31820477 [TBL] [Abstract][Full Text] [Related]
17. Association of clinical characteristics and lifestyle factors with fecal S100/calgranulin concentrations in healthy dogs. Heilmann RM; Guard MM; Toresson L; Unterer S; Grellet A; Grützner N; Suchodolski JS; Steiner JM Vet Med Sci; 2021 Jul; 7(4):1131-1143. PubMed ID: 33751838 [TBL] [Abstract][Full Text] [Related]
18. S100A12: a noninvasive marker of inflammation in inflammatory bowel disease. van de Logt F; Day AS J Dig Dis; 2013 Feb; 14(2):62-7. PubMed ID: 23146044 [TBL] [Abstract][Full Text] [Related]
19. Enzyme-Linked Immunosorbent Assay to Measure S100A12 in Fecal Samples of Children and Adults. Leach ST; Day AS Methods Mol Biol; 2019; 1929():755-761. PubMed ID: 30710309 [TBL] [Abstract][Full Text] [Related]
20. Fecal calprotectin and S100A12 have low utility in prediction of small bowel Crohn's disease detected by wireless capsule endoscopy. Sipponen T; Haapamäki J; Savilahti E; Alfthan H; Hämäläinen E; Rautiainen H; Koskenpato J; Nuutinen H; Färkkilä M Scand J Gastroenterol; 2012 Jul; 47(7):778-84. PubMed ID: 22519419 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]